Transplantation and cellular therapy
NT-proBNP Levels after First-Dose Post-Transplant Cyclophosphamide Predict Early Cardiac Events and Mortality in Allogeneic Stem Cell Transplantation.
Tzu-Ting Chen, Ching-Chan Lin, Shing-Ting Wang, Chia-Yu Chen, Mei-Chan Lin, Ching-Yun Hsieh, Chen-Yuan Lin, Su-Peng Yeh, Chang-Fang Chiu
Published: 202510.1016/j.jtct.2025.12.945
Abstract
Post-transplant cyclophosphamide (PTCy) is an effective method for preventing graft-versus-host disease (GVHD) following haploidentical hematopoietic stem cell transplantation (HSCT). However, PTCy is associated with significant toxicities, including…
Preview only. Read the full abstract at the source